Royce & Associates’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.7M | Buy |
|
|||||
|
2025
Q2 | $9.04M | Buy |
|
|||||
|
2025
Q1 | $9.03M | Sell |
|
|||||
|
2024
Q4 | $9.73M | Buy |
|
|||||
|
2024
Q3 | $11.8M | Buy |
|
|||||
|
2024
Q2 | $9.69M | Buy |
|
|||||
|
2024
Q1 | $11.2M | Buy |
|
|||||
|
2023
Q4 | $4.4M | Buy |
|
|||||
|
2023
Q3 | $474K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $336K | Sell |
|
|||||
|
2022
Q3 | $454K | Sell |
|
|||||
|
2022
Q2 | $8.16M | Buy |
|
|||||
|
2022
Q1 | $5.93M | Sell |
|
|||||
|
2021
Q4 | $6.05M | Buy |
|
|||||
|
2021
Q3 | $3.46M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $29K | Sell |
|
|||||
|
2019
Q3 | $28K | Buy |
|
|||||
|
2019
Q2 | $19K | Buy |
|
|||||
|
2019
Q1 | $17K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $3.29M | Sell |
|
|||||
|
2018
Q1 | $4.34M | Buy |
|
|||||
|
2017
Q4 | $2.53M | Buy |
|